Last reviewed · How we verify
NCT03880786
Implantation of a Pudendal PNA Test Lead for Neuromodulation by the ENTRAMI Technique in Case of Chronic Perineal Pain Syndrome.
NA trial testing pudendal PNE test lead in Pudendal Impingement Syndrome in 21 participants. Completed in 9 November 2021.
9 November 2021
Quick facts
| Lead sponsor | Brugmann University Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 21 |
| Start date | 8 January 2019 |
| Primary completion | 9 November 2021 |
| Estimated completion | 9 November 2021 |
| Sites | 1 location across Belgium |
Drugs / interventions tested
- pudendal PNE test lead
Conditions studied
- Pudendal Impingement Syndrome — all drugs for Pudendal Impingement Syndrome →
Sponsor
Brugmann University Hospital
Who can join
18 and older, any sex, with Pudendal Impingement Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Pudendal nerve release surgery in case of pudendal impingement syndrome is well described in literature.Pudendal nerve modulation in case of chronic perineal pain is also a promising technique and some small studies exist. However, in the latter group, patient inclusion criteria are very heterogenous and so conclusions about efficacy are difficult to draw. In the surgery group, outcome results also vary between the different approaches but in general, there is room for improvement. After pudendal nerve release in chronic perineal pain syndrome, it can take up to 6 months before improvement for the patient is recorded. This is partially due to the complex chronic pain syndrome mechanism. Nothing is known about the possible effect of early neuromodulation at the level of the pudendal nerve after his release. Recently, two cadaveric studies were published which described a minimal invasive trans gluteal approach for pudendal nerve decompression and a pudendal electrode placement. In the present trial, the investigators would like to combine the endoscopic trans gluteal pudendal release with pudendal neuromodulation to improve the outcome for patients suffering from pudendal impingement syndrome. The aim is to improve the results of pain score and quality of life of patients undergoing surgery for pudendal release in case of chronic perineal pain syndrome.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Pilot study: pudendal neuromodulation combined with pudendal nerve release in case of chronic perineal pain syndrome. The ENTRAMI technique: early results.
Jottard K, Bruyninx L, Bonnet P, Mathieu N, et al · · 2021 · cited 6× · PMID 33048179 · DOI 10.1007/s00192-020-04565-1
Verify or expand the search:
- PubMed search for NCT03880786
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Brugmann University Hospital trials
Trials by the same sponsor.
- NCT07267403 — Comparison of Modulations of Motor Brain Activity and SedLine After Median Nerve Stimulation in General Anesthesia · NA · recruiting
- NCT07267416 — Impact of Combined PSi + NIRS Monitoring in the Prevention of Postoperative Cognitive Disorders in Cardiac Surgery. · NA · recruiting
- NCT07413315 — Benefits of a Renal Rehabilitation Program Adapted to Uremic Patients on Daily Hemodialysis at Low Dialysate Flow Rate. · NA · recruiting
- NCT06292377 — Better Understanding of Fatigue After STroke · NA · recruiting
- NCT06160232 — Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03880786 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Brugmann University Hospital
- Last refreshed: 4 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03880786.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing